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HEALTH CARE USE & POLICY STUDIES – Prescribing Behavior & Treatment 
Guidelines
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An EvALUATIOn Of THE USE Of AnTIBIOTICS In A TEACHInG HOSPITAL In 
BAHAwALPUR
Ahmad M., Bashir A., Farooq Z., Pervaiz F., Akhtar M.
The Islamia University of Bahawalpur, Bahawalpur, Pakistan
Objectives: Antibiotics are among the most commonly prescribed drugs globally. 
Now a days overuse and inappropriate use of antibiotics have become a very seri-
ous issue in Pakistan and a very limited data is available on the use of antibiotics 
in Pakistan. The study was aimed to evaluate frequency, rates of incorrect prescrib-
ing and inappropriate use of antibiotics and to identify any opportunity for its 
improvement. MethOds: This prospective and point prevalence surveillance study 
was performed on April 19, 2013 at Bahawal Victoria Hospital, Bahawalpur. Data of 
all hospitalized patients on antibiotic therapy were collected on a standardized 
questionnaire. Results: Out of 692 patients 483 (69.8%) patients were given one 
or more antibiotics. Out of these 483 patients the antibiotic therapy was inappro-
priate in 266 (55.1%) patients. In 18 (3.7%) patients antibiotic therapy was given on 
microbiological assay bases while in 465 (96.3%) patients on empirical bases. The 
wards with the highest rate of antibiotic use were in ENT (96.8%), ophthalmology 
(96.2%) and urology (95.2%) while highest rate of antibiotic inappropriate use were 
in pediatrics (90.0%), neurosurgery (88.0%) and dermatology (66.7%). cOnclusiOns: 
Overuse, misuse and inappropriate use of antibiotics were detected in this hospital. 
A close surveillance regarding antibiotic use in hospitals and the forming of new 
policies concerning antibiotics use is strictly required to improve the appropriate 
use of antibiotics.
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PROSPECTIvE STUDY On PRESCRIPTIOn PATTERn In TERTIARY CARE HOSPITAL 
In SOUTH InDIA
Sirisha S.1, Goluguri R.R.1, Varghese A.1, Thomas S.M.1, Naik V.2
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Objectives: The main objective of the study is to evaluate the components of 
the prescription pattern and to determine the physicians written prescription 
non-compliance to the in-house guidelines of tertiary care hospital. MethOds: 
A prospective study with outpatients as study subjects are carried out in a tertiary 
care hospital, for a period of two months. A separate prescription audit checklist is 
used to see the completeness of the prescription according to in-house guidelines 
of tertiary care hospital which includes patients, physician and drug related infor-
mation. Results: A total of 2200 prescriptions assessed, with respect to patient 
information 52% of patient’s age and 52% of patient’s gender were missed. Regarding 
physician information 100% prescriptions contained the signature of the physician. 
Regarding the drug related information out of 2200 prescriptions (57.7%) brand 
names were found and 23.9% of drugs were not in capital and 2.5% appropriate 
abbreviations found, 8.% of prescriptions were missing the dosage and 4.7% was 
missing the route of administration 6.04% were missing the frequency, 7.22% were 
missing the duration, 1.18% were missing the dosage form, 0.09% of drug substitu-
tion,5.63 % were missing the directions for use and 20.68% of prescriptions were 
polypharmacy,1.40% Prescriptions were illegible,0.36% were missing the registration 
number. cOnclusiOns: The main findings concluded majority of the practition-
ers are not writing the generic names and which were not in the block letters. 
Also information of patient demographics which included gender and age were not 
mentioned. This study proved non-adherence to in-house guidelines by physicians 
and incompleteness of prescription.
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Objectives: Malnutrition (i.e. under-nutrition and over-nutrition) is among the 
top healthcare issues that can be fatal if proper nutrition-care is not provided 
by healthcare providers. Until now this problem is equally affecting adults as 
well as children because of healthcare providers’ inadequate knowledge, poor 
attitudes and inappropriate practices (closely monitoring patients’ health status 
and regularly reviewing their treatment plan to make sure patients’ nutritional 
needs are being met). The aim of this KAP study was to evaluate the knowledge, 
attitudes, and practices of healthcare providers (doctors, pharmacists and nurses) 
towards nutrition support in a tertiary care hospital in Pakistan. MethOds: A 
cross-sectional study was conducted on a newly developed and validated self-
administered research tool. Face and content validity of the research tool was done 
by various healthcare individuals including academics, surgeons, pharmacists and 
senior nurses. The research tool was also piloted on 15 healthcare providers in a 
different hospital before start of the study. Only registered healthcare providers 
of Pakistan were approached to take part in the study. A p-value < 0.05 was con-
sidered statistically significant. Results: Total 200 participants out of 350 took 
part into the study. Among the respondents, doctors (33.7%) expressed greater 
knowledge than pharmacists (26.7%) and nurses (21.2%). All doctors, pharmacists 
and nurses showed indecisive attitudes toward nutrition support to the patients. 
However, in the practice assessment, pharmacists had a slightly higher score. 
Only 19.4% respondents stated that they perform nutrition screening on admis-
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THE RELATIOnSHIP BETwEEn DISABILITY AnD MIGRATIOn STATUS In CHILE: 
PRELIMInARY AnALYSIS fROM REPEATED CROSS-SECTIOnAL SURvEY
Cabieses B., Delgado I., Bernales M., Obach A.
Universidad del Desarrollo, Santiago, Chile
Objectives: Disability in Chile is a growing public health problem that causes 
deterioration of individual wellbeing, family burden and premature mortality. 
The distribution of disability among immigrants has been under-researched. The 
objective was to explore crude and adjusted associations between total disabil-
ity and immigration status (immigrant versus Chile) in Chile between 2006 and 
2009. MethOds: Exploratory secondary analysis of nationally representative, 
anonymous survey CASEN 2006 and 2009 (n2006 = 268 873; n2009 = 246 924 partici-
pants). The relationship between self-reported total disability (dependent variable) 
and immigration status (independent variable) was modeled using weighted logistic 
regression. Adjustment variables were demographics (DG: age, sex, ethnicity, region, 
rural/urban residence, marital status) socioeconomic status (SES: household income 
and education). Analysis was conducted in STATA 13. Results: Self-reported preva-
lence of disability in Chile, according to CASEN 2006 and 2009, was 6.9% and 7.6%, 
respectively; more prevalent in women than men and with a clear inverse gradient 
according to income (4.8% richest quintile versus 9.6% poorest quintile). Immigration 
in Chile increased from 1% to 1.3%. Multivariate analysis indicated that the total 
population of immigrants have a lower chance of reporting disability (OR= 0.49; 
95%C= 0.37-0.66), even after adjusting for DG. However, this protection disappeared 
after adjusting for SES (OR= 0.75; 95% CI= 0.45-1.25). These results did not change 
significantly between 2006 and 2009. cOnclusiOns: We found a healthy migrant 
effect on the total population, which disappears after adjusting for socioeconomic 
variables. More robust analysis needs to be conducted to test these findings, ideally 
with longitudinal data. This is an urgent global health matter.
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Objectives: The territories are diverse and human settlements converge on it at 
a local and global scenario. These populations have varying degrees of socioeco-
nomic and health vulnerability, and this is important to monitor for policy and 
practice. We explored the spatial distribution of social and health vulnerability of 
international immigrants in Chile based on 2002-2012 Census data. MethOds: 
Exploratory study of spatial vulnerability of international immigrants in Chile using 
2002-2012 Census data. The total population was the comparison groups. Spatial 
vulnerability was measured at borough level for the entire Chilean territory (n= 339 
for 2002 and n= 343 for 2012) using three unique dimensions of the Index of Multiple 
Deprivation (binary variables: disability rate, primary education rate, unemployment 
rate). Pearson correlation tests were used to test the difference in rates of social and 
health vulnerability measures between the immigrant and the total population in 
the country. Results: According to Census 2012, 320,850 international migrants live 
in Chile (2% total population, similar to 2002). They are largely concentrated in the 
north (15% for 2012 and 6% for 2002) and centre (60% in 2012 and 48% in 2002). There 
was a significant correlation between separate and combined measures of IMD 
for both the entire population (R= 0.95), and for international immigrants (R= 0.95). 
Generally, both the total population and immigrants were more concentrated at the 
borough level when there were higher degrees of social and health vulnerability and 
these remained the same between 2002 and 2012. cOnclusiOns: Geographic loca-
tion of the total Chilean population and especially of international immigrants var-
ies depending on the degrees of social and health vulnerability and we can observe 
this trend for last ten years. The correlation between spatial location and vulner-
ability among immigrants was significant and consistent over a 10 years period.
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Zarate V.1, Kind P.2
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Objectives: To estimate a country-level value set for the 243 health states of the 
EQ-5D instrument in Chile. MethOds: A probabilistic sample from the Chilean 
adult population (N= 1,695) was selected to value a group of 31 EQ-5D health states 
using the time trade-off method between August 2013 and January 2014. Each 
respondent assessed a pre-defined subset of health states from the EQ-5D 3 level 
version and their values were used to fit several econometric models. Besides the 
10 dummy variables that represent the effect of health problems in each of the 2 
levels (i.e. moderate and severe) of the 5 dimensions of the instrument, a group of 
10 other interaction variables were also considered to improve statistical perfor-
mance. The final model was chosen applying criteria of 1) parsimony 2) goodness 
of fit and 3) high prediction capacity. The extrapolation was performed based on 
the chosen model to estimate the totality of 243 health states generated by the 
EQ-5D system. Results: A pooled least square model was selected, which included 
only the 10 main effects EQ-5D dummies plus a constant. The model was robust 
with an R2 of 0.26, MAE of 0.047 and a good predictive capacity (11 of the 31 health 
states had an estimated residual error higher than 0.05). The selected model was 
also parsimonious, considering only 11 variables. cOnclusiOns: It was possible 
to successfully extrapolate the valuation for the 243 EQ-5D health states in order 
to construct a country-level social value set. The final model differs from mod-
els developed in other countries and also from the previously reported model in 
Chile in 2008, which was constructed using data collected only in the Metropolitan 
Region. Our findings support the continuous methodological improvements of Cost-
effectiveness analyses in Chile and highlight the importance of large-scale surveys 
to adequately reflect the preference of the society as a whole.
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and intensity relative numbers. Results: In 2002, a total of 151,220 members were 
registered in 35 funds, increasing to 1,033,615 members in 31 funds by 2013. The 
total revenue of the health funds was HUF 6.699 billion in 2002, HUF 35.097 billion 
in 2007, and HUF 50.923 billion in 2013. The distribution of health fund payments 
as a percentage of consumption showed: in 2007, 88.4% supplementary health 
insurance services, including 16% supplementary services within the framework 
of social security benefits, 77% self-care services provided by the health funds (67.1% 
medicine, 31.2% medical device), while in 2013, 98.2% supplementary health insur-
ance services, including 18.6% supplementary services within the framework of 
social security benefits, 80.7% self-care services provided by the health funds (71.2% 
medicine, 28% medical device). Health fund payments for lifestyle improvement 
services reached 11.6% in 2007, and 1.5% in 2013. cOnclusiOns: Reduction in the 
number of health funds, and an increase both in membership and revenues indicate 
the consolidation of the function of health funds. The distribution of payments 
by consumption shows no significant progress: medicine and medical device still 
play a major role, and disease prevention and health care services still represent 
a very small proportion.
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Neumann P.J.1, Saret C.J.2
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Objectives: In the United States, Section 114 of the Food and Drug Modernization 
Act of 1997 (FDAMA) governs pharmaceutical companies’ promotion of health 
economic information to payers. Research shows that while payers frequently 
seek cost-effectiveness information, drug companies may hesitate to promote 
it because the law is unclear. The Food and Drug Administration (FDA) has not 
offered further guidance, although it suggested that it plans to publish draft guid-
ance in 2015. We developed hypothetical case studies of promotional claims and 
explored key questions about whether the FDA would allow them under Section 
114. MethOds: We created ten categories of potential claims: 1) Costing out on-
label clinical endpoints, 2) Promotion of a costing exercise to physicians working in 
an accountable care organization settings, 3) Burden of illness claims, 4) Economic 
analyses of a formulary restriction policy, 5) Extrapolations to doses, populations, 
or settings not covered in trials, 6) Adherence claims, 7) “Utilization of care” as 
a secondary endpoint in randomized clinical trials, 8) Costing out a competitor 
drug’s adverse event, 9) Economic analysis of comparative effectiveness claims 
using an indirect treatment comparison, and 10) Extrapolating from surrogate to 
long-term outcomes in an economic model. We developed a case study for each. 
We sought to balance examples across diseases and to address the components 
of Section 114: information type, connection to labeled indication, audience, and 
evidence quality. Results: Most cases fall into a “gray area” as to whether they are 
allowable under Section 114. In particular, there is a lack of clarity about whether 
claims meet requirements that they be “directly related” to approved indications 
and supported by “competent and reliable scientific evidence.” cOnclusiOns: 
This study reinforces the need for further guidance and/or legislation to clarify 
and possibly expand the Section. It also illustrates challenges the FDA faces in 
regulating this area.
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Objectives: There is a perception that the National Institute of Health and Care 
Excellence (NICE) has struggled to get clinical commissioning groups (CCGs) to 
follow guidelines. There is a legal obligation to follow NICE technology appraisal 
guidance (TAG) when these are accompanied by a funding direction; however it 
has long been considered that this was not the case for Clinical Guidelines (CGs) 
nor is there any right of appeal in relation to CGs. We seek to demonstrate that 
CGs could be effectively mandatory unless a reasoned justification is provided. 
The position is contrasted with respect to guidance from technology apprais-
als. MethOds: Case law and legislation are reviewed to compare the enforce-
ability of general guidelines and health technology appraisal-derived guidance. 
In particular Regina vs. North Derbyshire Health Authority, ex parte Fisher (1997) 
(Regina), and the recent decision of Rose vs. Thanet CCG (Rose) are referred to. 
We review both the CGs and TAGs issued and compare the strength and range of 
the recommendations. Results: The Reginacase established that a decision not 
to follow national policy was only lawful if there was some ‘special factor’, which 
‘exceptionally justified departure’. Disagreement with the policy was not enough. 
Following this, the recent Rose case considered that the CCG was under an implied 
obligation to give reasons for any general policy not to fund a particular inter-
vention, which suggests that the guidance is effectively mandatory unless there 
are special grounds. cOnclusiOns: Even if the Rose decision were successfully 
appealed or distinguishable, CCGs will need to consider special circumstances if 
they do not wish to implement a CG. Along with financial constraints on health 
budgets, this creates dilemmas for CCGs including local priority setting. Therefore, 
as the law stands, exceptional circumstances will need to be identified by CCGs 
taking a contrary decision to a CG.
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IRRATIOnAL DRUG USE PATTERn In HOSPITALS. A wARnInG fOR HEALTH 
CARE SYSTEM
Umer Jan S.
University of Balochistan, Quetta, Pakistan
sion, and 35% of them prefer to perform nutrition assessment during hospitaliza-
tion. cOnclusiOns: Inappropriate nutrition care from healthcare providers was 
possibly due to the lack of appropriate guidelines and insufficient knowledge. 
Special nutrition management trainings and continuing professional develop-
ment (CPD) courses will be of great help to improve KAP of healthcare providers 
towards nutrition.
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Objectives: The recent reforms and policy changes have increased the cost pres-
sures on all healthcare stakeholders, including clinical experts. In the past, clinical 
guidelines were developed independent of cost or economic considerations. However, 
increasingly, more clinical guidelines are mentioning cost concerns and referring to 
economic data in new recommendations. The objective of this study was to ana-
lyze trends in the use of health economic information for developing clinical guide-
lines. MethOds: A systematic literature search was undertaken for the databases 
Pubmed, Embase, Biosis, Google Scholar, and Cochrane. The guidelines published 
between 2003-2012 were included. For guidelines which met the search criteria, data 
was collected for the name of the authors, indication, year of publication, country/
region, and context of use of cost/economic evidence. Results: Sixteen clinical 
guidelines published between 2003-2014 met the inclusion criteria for specific men-
tion of cost/economic evidence. More than 50% of these guidelines were published 
between 2006-2014. For indication, 3 out of 16 guidelines were for diabetes, while 
the rest were for different indications. In these16 guidelines “cost effectiveness” was 
mentioned 14 times, either referencing cost-effectiveness data or to mention the 
importance of such data for selecting treatment options. The guidelines commonly 
cite high cost of disease or high economic burden as one of the considerations for 
developing new recommendations (11 out of 16). Another term that was commonly 
used by these guidelines was “cost-benefit,” which was mentioned 5 times in these 
guidelines. Notably, QALY was rarely mentioned (1 out of 16 times) in these guide-
lines. cOnclusiOns: This analysis suggests that some clinical experts groups are 
increasingly showing willingness to use and incorporate health economic information 
for developing new recommendations. Findings from this study might aid drug and 
device manufacturers in understanding the context of use of such information and 
allow them to tailor their product development plans for generating such evidence.
HEALTH CARE USE & POLICY STUDIES – quality of Care
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EffECTIvEnESS Of InTERvEnTIOnS fOR DRUG PRESCRIBInG IMPROvEMEnT 
In PRIMARY HEALTH CARE
Zavala-González M.A., Cabrera-Pivaral C.E., Orozco-Valerio M.J.
University of Guadalajara, Guadalajara, Mexico
Objectives: To determine effectiveness of interventions for drug prescribing 
improvement in primary health care units. MethOds: Systematic review and 
meta-analysis. Was held a quest in MedLine©, ScienceDirect©, Springer©, SciELO©, 
Dialnet©, RedALyC© and Imbiomed©, since indexation date of each database until 
August 2014. Were utilized keywords “drug prescribing”, “intervention studies” and 
“primary health care” with your synonyms. Were included quantitative studies, 
experimental and quasi-experimental, wrote in Spanish, English or Portuguese, 
and published in any country, with CASP-score equal or major than five, where 
drug-prescribing quality was evaluated accord to physicians’ adherence to drug 
posology and mexican guidelines for diseases treatment. Were excluded stud-
ies without raw data, qualitative studies, systematic reviews, protocols, essays, 
government documents, non-pharmacologic or alternative treatment studies 
and gray literature. Odds ratios (OR) with 95% interval confidence (p≤ 0,05) were 
obtained. Results: Were found 522 publications, were excluded 405 for title, 
99 for abstract and 9 for full text. Were included 3 references of the references. 
Don’t found references’ citations. Were analyzed 12 articles that reported 17 inter-
ventions: 64,7% educative, 23,5% incorporating of degreed in pharmacy to the 
health team, and 11,8% software utilization. The association forces “intervention/
improvement” obtained were: educative interventions OR= 2,47 (IC95% 2,28, 2,69), 
incorporating of degreed in pharmacy to the health team OR= 3,28 (IC95% 2,58, 
4,18), and software utilization OR= 10,16 (IC95% 8,81, 11,71). cOnclusiOns: The 
software utilization interventions showed major effectiveness for to improve-
ment drug prescribing quality, versus educative interventions and incorporation 
of degreed in pharmacy to the health team. However, educative interventions may 
have a better cost-benefit relationship.
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Objectives: Hungary runs a compulsory, solidarity based health insurance based 
system with a single payer. However, there is an increasing market of voluntary 
health insurance schemes and funds. The aim of this study is to analyze the vol-
untary health insurance market in Hungary. MethOds: Our analysis is based on 
annual data from 2002 to 2013. The analysis of the number of funds and membership 
figures is based on end of the year data, the analysis of services and payments is 
based on annual data. We performed time series analysis and calculated dynamic 
